Omacor

Description overdue on 23.08.2011

Related Articles:

• Neostigmine, product description
• Reviews Amara M
• Reviews Ibufene
• Candles Viburkol, instructions and price in Ukraine

Tweet

Omacor is lipid-lowering drugs Containing essential fatty acids such as docosahexaenoic   and Eicosapentaenoic acid . This drug reduces the content triglycerides   and it has an active effect on hemostasis Because it reduces the synthesis thromboxane   and increases the blood clotting. Furthermore, it retards the drug triglyceride synthesis in the liver, which in turn causes an increase in fatty acid oxidation.

According to the results of observations in patients who were taking Omacor over one gram per day, decreased mortality and incidence heart attack   and stroke .

Indications:

Patients discharged Omacor in the prevention of heart attack along with ACE inhibitors, antiagregatnymi means   and platens . It is also recommended for mixed and endogenous hyperlipoproteinemia .

Dosage:

Omacor be taken inside, during the meal. For the prevention of myocardial dosage is one capsule per day, for the treatment of hypertriglyceridemia   - twice as much. In the absence of effective dose can be increased, but no more than up to four capsules per day. The duration of therapy is determined individually.

Side effects:

During the use of the drug may occur, these side effects: nausea, dyspepsia , Gastritis, gastrointestinal disorders, abdominal pain, gastroenteritis , Vomiting, constipation . flatulence ; headache, dysgeusia, dizziness; hypersensitivity reactions; dry nose; decrease in blood pressure; hyperglycemia; itchy rash, acne, rash. In very rare cases, after prolonged use of Omacor experienced higher levels LDH   and CK , An increase of ALT, AST, weight gain; acne   and eczema .

Contraindications:

Omacor is contraindicated in case of hypersensitivity, lactation, pregnancy, exogenous hypertriglyceridemia. With care it is necessary to designate people with impaired liver function, during surgery, serious injury to persons younger than 18 and older than 70 years.

Special instructions:

For patients who have increased the dosage must constantly monitor the doctor. It should be noted that people with risk hemorrhage   may increase bleeding. At the same time taking Omacor and fibrates is not recommended. May increase in liver transaminases.

In pediatrics the drug should be avoided. Omacor is hardly affects the ability to control any drive mechanisms and vehicles.

Overdose:

In overdose Omacor may appear or increase the side effects. In order to carry out their treatment therapy, in accordance with emerging symptoms.

Drug Interactions:

The risk of prolonging bleeding occurs when you use a Omacor oral anticoagulants . This medication can be administered together with warfarin As complications. Although, if you combine the reception of these two drugs, and then stop the course of Omacor, the prothrombin time should be monitored.

Supply of pharmacies:

Omacor released strictly on doctor's prescription.

Terms and conditions of storage:

This drug should be stored in a place where not penetrate direct sunlight, which can not penetrate the children, and where the temperature does not exceed twenty-five degrees Celsius. Omacor is kept for three years; It is strictly prohibited to use the medication after the expiration date.